Viewing Study NCT00116792


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT00116792
Status: UNKNOWN
Last Update Posted: 2007-05-17
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions
Sponsor: Gold, Herman K., MD
Organization:

Organization Data

Organization:
Class: INDIV
Study ID: 2003P-001717
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDIV
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View